Name

Dexrazoxane

Alternate Names

ADR-529
ICRF-187
Zinecard

Abbreviations

None

Category

Ancillary Agent

Subcategory

Cardioprotectant

NSC Number

169780

Primary Site

None

Histology

None

Remarks

A cardioprotective agent, may have synergistic activity when given with other antineoplastic drugs. FDA approved for reducing cardiomyopathy related doxorubicin. Little if any antitumor effect in multiple studies of various cancers.

Coding

This drug should NOT be coded
Glossary